Cargando…

Effects of Febuxostat on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: To investigate the association between using febuxostat and cardiovascular events. METHODS: Systematic search of randomized controlled trials was performed using PubMed/MEDLINE, Cochrane review, and EMBASE databases through April 17, 2019. Meta-analysis was performed using random effect m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Abdouh, Ahmad, Khan, Safi U., Barbarawi, Mahmoud, Upadhrasta, Sireesha, Munira, Srajum, Bizanti, Anas, Elias, Hadi, Jat, Asadulla, Zhao, Di, Michos, Erin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411164/ https://www.ncbi.nlm.nih.gov/pubmed/32793871 http://dx.doi.org/10.1016/j.mayocpiqo.2020.04.012

Ejemplares similares

Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Al-Abdouh, Ahmad, et al.
Publicado: (2021)

An Unusual Association between Neurofibromatosis Type 1 and Diffuse B Cell Lymphoma
por: Bizanti, Anas, et al.
Publicado: (2021)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis
por: Maniar, Yash M., et al.
Publicado: (2022)

Impact of Adjuvant Use of Midodrine to Intravenous Vasopressors: A Systematic Review and Meta-Analysis
por: Al-Abdouh, Ahmad, et al.
Publicado: (2021)

Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

Successful febuxostat desensitization in a patient with febuxostat hypersensitivity: A Malaysian experience
por: Sulaiman, Narisa, et al.
Publicado: (2017)

Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis
por: Yedlapati, Siva H., et al.
Publicado: (2021)

Reliability of focused cardiac ultrasound performed by first-year internal medicine residents at a community hospital after a short training
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

Cardiovascular Disease Mortality Among Hispanic Versus Non‐Hispanic White Adults in the United States, 1999 to 2018
por: Khan, Safi U., et al.
Publicado: (2022)

Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality
por: Jabri, Ahmad, et al.
Publicado: (2021)

Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
por: Pawar, Ajinkya, et al.
Publicado: (2021)

Febuxostat and Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Cuenca, John A., et al.
Publicado: (2019)

Febuxostat methanol solvate
por: Jiang, Qi-Ying, et al.
Publicado: (2011)

Febuxostat ethanol monosolvate
por: Gelbrich, Thomas, et al.
Publicado: (2020)

Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
por: Guan, Xudong, et al.
Publicado: (2022)

LEFT ATRIAL AND VENTRICULAR THROMBUS IN AN ADULT WITH MULTISYSTEM INFLAMMATORY SYNDROMECAUSED BY THE SARS-COV-2 B117 VARIANT
por: Upadhrasta, Sireesha, et al.
Publicado: (2023)

Income disparity and utilization of cardiovascular preventive care services among U.S. adults
por: Shahu, Andi, et al.
Publicado: (2021)

Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: A systematic review and meta‐analysis
por: Mhanna, Mohammed, et al.
Publicado: (2022)

Febuxostat and the Black Box Blues
por: Abeles, Aryeh M., et al.
Publicado: (2019)

Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
por: Shahid, Izza, et al.
Publicado: (2022)

Early Mechanical Circulatory Support for Cardiogenic Shock
por: Upadhrasta, Sireesha, et al.
Publicado: (2022)

Management of hyperuricemia in gout: focus on febuxostat
por: Reinders, Mattheus K, et al.
Publicado: (2010)

Febuxostat versus allopurinol for patients with gout: is it time to overcome concerns regarding cardiovascular safety?
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2021)

Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
por: Gao, Linggen, et al.
Publicado: (2021)

Cardiovascular risk and mortality in patients with hyperuricemia treated with febuxostat or allopurinol: a retrospective nation-wide cohort study in Austria 2014–2017
por: Weisshaar, Stefan, et al.
Publicado: (2022)

Gender Differences in Patient‐Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease
por: Okunrintemi, Victor, et al.
Publicado: (2018)

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
por: MacDonald, Thomas M, et al.
Publicado: (2014)

Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
por: Khan, Safi U., et al.
Publicado: (2021)

Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis
por: Zhang, Shengzhao, et al.
Publicado: (2021)

Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
por: Deng, Jian‐Hao, et al.
Publicado: (2022)

Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System
por: Bai, Yang, et al.
Publicado: (2023)

Efficacy and safety of febuxostat in elderly female patients
por: Mizuno, Tomohiro, et al.
Publicado: (2014)

Diabetes and gout: efficacy and safety of febuxostat and allopurinol
por: Becker, M A, et al.
Publicado: (2013)

Celebrating Versatility: Febuxostat’s Multifaceted Therapeutic Application
por: Kraev, Krasimir Iliev, et al.
Publicado: (2023)

Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout
por: Kamel, Bishoy, et al.
Publicado: (2022)

Stroke‐Related Mortality in the United States–Mexico Border Area of the United States, 1999 to 2018
por: Khan, Safi U., et al.
Publicado: (2021)

Modest Gains Confer Large Impact: Achievement of Optimal Cardiovascular Health in the US Population
por: Michos, Erin D., et al.
Publicado: (2021)

Demographic, Regional, and State‐Level Trends of Mortality in Patients With Aortic Stenosis in United States, 2008 to 2018
por: Khan, Safi U., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qrinpc9l9pc6rf3b8eum5o55vj